Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANDA User Fees: Negotiators Close To Agreement, But Backlog Is Sticking Point

Executive Summary

The generics industry does not appear satisfied with an FDA proposal to treat all applications equally under a new generic drug user fee program, preferring instead to create another, separate user fee that would clear the ANDA application backlog faster.
Advertisement

Related Content

GDUFA Launch Pains: Facility List Fluctuations, Back-Due Backlog Fees
Backlog Backfire: FDA Sees Increase In Pending Generic Applications At Deadline
As GDUFA Launch Nears, Is Sitting In The Backlog More Appealing?
ANDA User Fee Agreement Expected To Be Finished in Early September
Generic User Fees: API Manufacturers To Pay Less Than Finished Dose Firms
Generic User Fee Negotiators Struggling To Meet June Deadline
FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan
Generic User Fees Have Four-Month Negotiating Window As Differences Narrow
Generic User Fee Negotiations: Should Different Kinds Of ANDAs Pay More?
Generic User Fee Negotiations: Should Different Kinds Of ANDAs Pay More?

Topics

Advertisement
UsernamePublicRestriction

Register

PS053475

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel